Market Sectors
Latest News
Bactest is using the IBMS meeting in September (Birmingham NEC) to unveil the new DUOBAC Blood culture system.
GEMINI Diagnostics focusses on Human Health Sector technologies
Bactest welcomes the launch of a new web site dedicated to the prevention of Needlestick Injury.
Near Patient
Many reports have shown the potential advantages of “near patient” testing in terms of improved healthcare and reduced costs.
In the global market place, a great many countries are rapidly improving levels of healthcare. The logistical problems associated with transport of samples to central laboratories over long distances significantly limits the realistic aspirations that can be attached to this mission. The technical implications of transporting samples over significant distances with the implications of delays are severe and the reliability of tests highly impaired.
Although significantly more organised, with reliable infrastructures, western countries grapple with similar issues but often with shorter transport routes.
In both situations there are clear advantages in starting tests at the point of care.
Bactest is the only company which has adequately addressed the issues of, and provided solutions to those wishing to provide localised septicaemia testing, whether that is at an individual or laboratory level.
Bactest has also developed the only automated instrument able to tackle many of the logistical and technical issues facing the centralised routine laboratory. Gemini truly is a versatile system suitable for almost any laboratory.
Near Patient
Small and compact, with a footprint of only 25 cm x 8 cm, the instrument can be transported to the site of need.
Contact Us
